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Background: Drug eluting stents (DES) utilizing mTOR inhibitors reduce restenosis but are associated with accelerated neoatherosclerosis. 
Impaired endothelial barrier function (EBF) is likely contributor to neoatherosclerosis seen in DES. 
methods: Human aortic endothelial cells (HAEC) and mouse aortic endothelium (MAE) were examined to determine the effect of sirolimus (SRL), 
an mTOR inhibitor, on EBF. 
results: EBF, measured by transendothelial electrical resistance, was impaired in HAEC with SRL treatment or transfection with siRNA for FKBP12.6. 
This impairment was reversed when pretreated with ryanodine, a stabilizer of RyR2 Ca2+ release channels. Intracellular Ca2+ increased in HAEC 
treated with SRL and normalized with ryanodine. HAEC treated with SRL demonstrated increases in PKCalpha phosphorylation, a serine/threonine 
kinase important in VE cadherin barrier function through its interaction with p120-catenin. Immunostaining of both HAEC and MAE showed disruption 
of VE cadherin (green) and p120 (red) in cells/aortas treated with SRL (figure). SRL impairment of EBF was abolished by HAEC transfection with 
PKCalpha siRNA. Mice treated with SRL demonstrated increased MAE permeability measured by Evans blue. 
conclusion: SRL binding to FKBP12.6 impairs EBF by increasing intracellular Ca2+ concentration leading to PKCalpha activation and disruption of 
the VE Cadherin-p120 interaction. Poor EBF may contribute to accelerated neoatherosclerosis seen within DES that utilize mTOR inhibitors. 
